WeTrials
Recruiting

Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects With Non-Small Cell Lung Cancer With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

What is this study?

This clinical trial is testing an experimental medication called APL-101 for people with specific types of advanced cancer, especially non-small cell lung cancer, that have certain gene changes known as MET alterations. Researchers want to see how safe the drug is, how it moves through the body, and how well it works to fight the cancer.

Who can participate?

Adults aged 18 and older who have been diagnosed with advanced solid tumors or non-small cell lung cancer with specific genetic changes may be eligible. Participants must meet certain health requirements and may need to have specific treatment histories depending on their cancer type.

What will happen?

Participants will take the experimental study drug, APL-101, by mouth in capsule form. Doctors will closely monitor participants' health, check how well the treatment is working, and watch for any side effects throughout the study.

Where and when?

This study is currently recruiting participants at multiple locations across the United States, including cities in California, Florida, and Massachusetts.

Key Points
  • 1Testing an experimental targeted cancer therapy called APL-101 taken as a capsule.
  • 2Focuses primarily on advanced cancers and lung cancers with specific MET gene changes.
  • 3Currently recruiting patients at multiple medical centers in the United States.

No related links yet

Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Solid TumorsAdvanced CancerRenal CancerGastric CancerGastroesophageal Junction AdenocarcinomaNSCLCLung CancerBrain TumorGlioblastoma MultiformeEGFR Gene MutationMET AmplificationHGFThyroid CancerPancreatic CancerColon CancerMET AlterationMET FusionExon 14 Skipping

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.